The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 21, 2022 | Chung Dong Chune Christopher | Chief Medical Officer | Disposed to issuer(D) | 83K | $33.50 | $2.8M |
| Jul 21, 2022 | Chung Dong Chune Christopher | Chief Medical Officer | Grant(A) | 35K | — | $0 |
| Jul 21, 2022 | Chung Dong Chune Christopher | Chief Medical Officer | Disposed to issuer(D) | 35K | $12.82 | $453K |
| Jul 21, 2022 | Noll Austin Francis III | Executive VP and CCO | Grant(A) | 62K | — | $0 |
| Jul 21, 2022 | Noll Austin Francis III | Executive VP and CCO | Disposed to issuer(D) | 201K | $33.50 | $6.7M |
| Jul 21, 2022 | Noll Austin Francis III | Executive VP and CCO | Disposed to issuer(D) | 73K | $12.82 | $930K |
| Jul 21, 2022 | Davies Benjamin Drew | Executive VP and CFO | Disposed to issuer(D) | 182K | $33.50 | $6.1M |
| Jul 21, 2022 | Davies Benjamin Drew | Executive VP and CFO | Grant(A) | 106K | — | $0 |
| Jul 21, 2022 | Sullivan Thomas Joseph | President and CEO, Director | Disposed to issuer(D) | 721K | $33.50 | $24.2M |
| Jul 21, 2022 | Sullivan Thomas Joseph | President and CEO, Director | Grant(A) | 649K | — | $0 |
| Jul 21, 2022 | Daskal Ilan | Director | Disposed to issuer(D) | 19K | $33.50 | $634K |
| Jul 21, 2022 | Guerin Eric | Director | Disposed to issuer(D) | 10K | $33.50 | $339K |
| Jul 21, 2022 | Heine Lisa Wipperman | Director | Disposed to issuer(D) | 26K | $33.50 | $881K |
| Jul 21, 2022 | Levine Joshua | Director | Disposed to issuer(D) | 37K | $33.50 | $1.3M |
| Jul 21, 2022 | Moore Bryant M | Director | Disposed to issuer(D) | 10K | $33.50 | $339K |
| Jul 21, 2022 | Schroeder Alice D. | Director | Disposed to issuer(D) | 22K | $33.50 | $751K |
| Jun 15, 2022 | Daskal Ilan | Director | Grant(A) | 5K | — | $0 |
| Jun 15, 2022 | Guerin Eric | Director | Grant(A) | 4K | — | $0 |
| Jun 15, 2022 | Heine Lisa Wipperman | Director | Grant(A) | 5K | — | $0 |
| Jun 15, 2022 | Levine Joshua | Director | Grant(A) | 5K | — | $0 |
| Jun 15, 2022 | Moore Bryant M | Director | Grant(A) | 4K | — | $0 |
| Jun 15, 2022 | Schroeder Alice D. | Director | Grant(A) | 5K | — | $0 |
| Jan 4, 2022 | Davies Benjamin Drew | Executive VP and CFO | Tax withholding(F) | 1K | $24.02 | $30K |
| Jan 4, 2022 | Noll Austin Francis III | Executive VP and CCO | Tax withholding(F) | 4K | $24.02 | $89K |
| Jan 4, 2022 | Chung Dong Chune Christopher | Chief Medical Officer | Tax withholding(F) | 3K | $24.02 | $67K |
| Jan 3, 2022 | Chung Dong Chune Christopher | Chief Medical Officer | Grant(A) | 14K | $24.00 | $338K |
| Jan 3, 2022 | Sullivan Thomas Joseph | President and CEO, Director | Grant(A) | 52K | $24.00 | $1.3M |
| Jan 3, 2022 | Noll Austin Francis III | Executive VP and CCO | Grant(A) | 26K | $24.00 | $615K |
| Jan 3, 2022 | Davies Benjamin Drew | Executive VP and CFO | Grant(A) | 19K | $24.00 | $464K |
| Jan 2, 2022 | Chung Dong Chune Christopher | Chief Medical Officer | Tax withholding(F) | 4K | $23.73 | $96K |
| Jan 2, 2022 | Noll Austin Francis III | Executive VP and CCO | Tax withholding(F) | 5K | $23.73 | $116K |
| Jan 2, 2022 | Davies Benjamin Drew | Executive VP and CFO | Tax withholding(F) | 4K | $23.73 | $86K |
| Dec 31, 2021 | Chung Dong Chune Christopher | Chief Medical Officer | Grant(A) | 2K | $23.73 | $56K |
| Dec 31, 2021 | Chung Dong Chune Christopher | Chief Medical Officer | Tax withholding(F) | 1K | $23.73 | $29K |
| Dec 31, 2021 | Noll Austin Francis III | Executive VP and CCO | Tax withholding(F) | 2K | $23.73 | $38K |
| Dec 31, 2021 | Noll Austin Francis III | Executive VP and CCO | Grant(A) | 4K | $23.73 | $87K |
| Dec 31, 2021 | Davies Benjamin Drew | Executive VP and CFO | Grant(A) | 5K | $23.73 | $125K |
| Dec 31, 2021 | Davies Benjamin Drew | Executive VP and CFO | Tax withholding(F) | 2K | $23.73 | $59K |
| Dec 9, 2021 | Chung Dong Chune Christopher | Chief Medical Officer | Option exercise(M) | 12K | $20.68 | $244K |
| Dec 9, 2021 | Chung Dong Chune Christopher | Chief Medical Officer | Sell(S) | 12K | $23.08 | $272K |
| Dec 9, 2021 | Chung Dong Chune Christopher | Chief Medical Officer | Option exercise(M) | 12K | $20.68 | $244K |
| Oct 1, 2021 | Davies Benjamin Drew | Executive VP and CFO | Tax withholding(F) | 3K | $25.86 | $69K |
| Aug 18, 2021 | Moore Bryant M | Director | Grant(A) | 6K | $25.87 | $150K |
| Aug 18, 2021 | Guerin Eric | Director | Grant(A) | 6K | $25.87 | $150K |
| Jun 17, 2021 | Sullivan Thomas Joseph | Director | Grant(A) | 5K | $28.77 | $150K |
| Jun 17, 2021 | Paul Barbara R | Director | Grant(A) | 5K | $28.77 | $150K |
| Jun 17, 2021 | Levine Joshua | Director | Grant(A) | 5K | $28.77 | $150K |
| Jun 17, 2021 | Heine Lisa Wipperman | Director | Grant(A) | 5K | $28.77 | $150K |
| Jun 17, 2021 | Schroeder Alice D. | Director | Grant(A) | 5K | $28.77 | $150K |
| Jun 17, 2021 | Daskal Ilan | Director | Grant(A) | 5K | $28.77 | $150K |
| Jun 11, 2021 | Schroeder Alice D. | Director | Sell(S) | 3K | $27.49 | $81K |
| Jun 11, 2021 | Daskal Ilan | Director | Sell(S) | 3K | $27.46 | $69K |
| Jun 1, 2021 | Chung Dong Chune Christopher | VP of Medical Affairs | Sell(S) | 13K | $27.55 | $344K |
| May 28, 2021 | Chung Dong Chune Christopher | VP of Medical Affairs | Sell(S) | 808 | $26.90 | $22K |
| May 27, 2021 | Chung Dong Chune Christopher | VP of Medical Affairs | Sell(S) | 10K | $27.10 | $284K |
| May 25, 2021 | Chung Dong Chune Christopher | VP of Medical Affairs | Sell(S) | 9K | $27.41 | $259K |
| May 24, 2021 | Chung Dong Chune Christopher | VP of Medical Affairs | Sell(S) | 20K | $27.11 | $542K |
| May 20, 2021 | Chung Dong Chune Christopher | VP of Medical Affairs | Sell(S) | 9K | $27.00 | $251K |
| May 19, 2021 | Chung Dong Chune Christopher | VP of Medical Affairs | Sell(S) | 6K | $26.54 | $169K |
| May 18, 2021 | Chung Dong Chune Christopher | VP of Medical Affairs | Sell(S) | 3K | $26.90 | $78K |
| May 14, 2021 | Chung Dong Chune Christopher | VP of Medical Affairs | Sell(S) | 22K | $28.31 | $621K |
| May 13, 2021 | Chung Dong Chune Christopher | VP of Medical Affairs | Sell(S) | 28K | $27.96 | $775K |
| May 12, 2021 | Chung Dong Chune Christopher | VP of Medical Affairs | Sell(S) | 10K | $27.47 | $278K |
| Apr 30, 2021 | Noll Austin Francis III | Executive VP and CCO | Grant(A) | 489 | $21.72 | $11K |
| Apr 30, 2021 | Kennedy Jonathan | President and CEO, Director | Grant(A) | 489 | $21.72 | $11K |
| Jan 4, 2021 | Kennedy Jonathan | President and CEO, Director | Grant(A) | 200K | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-03-29 → 2026-07-11. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).